Heidelberg, Germany

Michael Kaus

This inventor holds 2 USPTO granted patents. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Kaus. Retrieved from https://idiyas.com/inventor/michael-kaus-p08y0b33

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Michael Kaus

Introduction: Michael Kaus, a distinguished inventor hailing from Heidelberg, Germany, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Michael Kaus holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in various sectors.

Career Highlights: With a career spanning over two decades, Michael Kaus has worked for leading tech companies, research institutions, and universities, where he has spearheaded projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Michael Kaus has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge exchange that has led to remarkable advancements in technology.

Conclusion: Michael Kaus's relentless pursuit of innovation, coupled with his passion for creating solutions to complex challenges, solidifies his position as a visionary inventor whose impact will be felt for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…